Name: Access: How do Good Health Technologies get to Poor People in Poor Countries? (Harvard Series on Population and International Health) (en Inglés)
Price: 97029.00 COP
Availability: InStock
Author: Laura Frost; Michael R. Reich
ISBN: 9780674032156

portada Access: How do Good Health Technologies get to Poor People in Poor Countries? (Harvard Series on Population and International Health) (en Inglés)

Formato

Libro Físico

Editorial

Harvard Center For Population And Development Studies

Autor

Laura Frost; Michael R. Reich

Año

2009

Idioma

Inglés

N° páginas

235

Encuadernación

Tapa Blanda

ISBN

0674032152

ISBN13

9780674032156

N° edición

Categorías

Economías emergentes

Access: How do Good Health Technologies get to Poor People in Poor Countries? (Harvard Series on Population and International Health) (en Inglés)

Laura Frost; Michael R. Reich (Autor) · Harvard Center For Population And Development Studies · Tapa Blanda

Libro Nuevo

$ 97.029

$ 149.276

Ahorras: $ 52.247

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 14 de Junio y el Martes 25 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Access: How do Good Health Technologies get to Poor People in Poor Countries? (Harvard Series on Population and International Health) (en Inglés)"

Many people in developing countries lack access to health technologies, even basic ones. Why do these problems in access persist? What can be done to improve access to good health technologies, especially for poor people in poor countries? This book answers those questions by developing a comprehensive analytical framework for access and examining six case studies to explain why some health technologies achieved more access than others. The technologies include praziquantel (for the treatment of schistosomiasis), hepatitis B vaccine, malaria rapid diagnostic tests, vaccine vial monitors for temperature exposure, the Norplant implant contraceptive, and female condoms. Based on research studies commissioned by the Bill & Melinda Gates Foundation to better understand the development, adoption, and uptake of health technologies in poor countries, the book concludes with specific lessons on strategies to improve access. These lessons will be of keen interest to students of health and development, public health professionals, and health technology developers - all who seek to improve access to health technologies in poor countries.